Infectious Bronchitis Virus - Variant Massachusetts S1 antibody and antigen (recombinant protein)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-VT-P154-Tg001-Ag01	Recombinant Infectious Bronchitis Virus - Variant Massachusetts S1 protein	3090
GMP-VT-P154-Tg001-Ab01	Anti-Infectious Bronchitis Virus - Variant Massachusetts S1 mouse monoclonal antibody (mAb)	1953
GMP-VT-P154-Tg001-Ab02	Anti-Infectious Bronchitis Virus - Variant Massachusetts S1 mouse monoclonal antibody (mAb)	1953
GMP-VT-P154-Tg001-Ab03	Anti-Infectious Bronchitis Virus - Variant Massachusetts S1 human monoclonal antibody (mAb)	1953
GMP-VT-P154-Tg001-Ab04	Anti-Infectious Bronchitis Virus - Variant Massachusetts S1 human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-VT-P154-Tg001-Ag01
Product Name	Recombinant Infectious Bronchitis Virus - Variant Massachusetts S1 protein
Pathogen	Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts)
Target/Biomarker	S1
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts) S1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts) level test of animal Avian/Bird/Poultry with Infectious Bronchitis Virus - Variant Massachusetts infection.
Tag	His
Products description	Recombinant Infectious Bronchitis Virus - Variant Massachusetts S1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-VT-P154-Tg001-Ab01, GMP-VT-P154-Tg001-Ab02
Product Name	Anti-Infectious Bronchitis Virus - Variant Massachusetts S1 mouse monoclonal antibody (mAb)
Pathogen	Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts)
Target/Biomarker	S1
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts) S1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts) antibodies in Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts) level test of animal Avian/Bird/Poultry with Infectious Bronchitis Virus - Variant Massachusetts infection.
Tag	mFc
Products description	Anti-Infectious Bronchitis Virus - Variant Massachusetts S1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-VT-P154-Tg001-Ab03, GMP-VT-P154-Tg001-Ab04
Product Name	Anti-Infectious Bronchitis Virus - Variant Massachusetts S1 human monoclonal antibody (mAb)
Pathogen	Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts)
Target/Biomarker	S1
Expression platform	CHO
Isotypes	Human IgG1
Bioactivity validation	Recombinant Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts) S1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts) antibodies in Infectious Bronchitis Virus - Variant Massachusetts (IBV - Variant Massachusetts) level test of animal Avian/Bird/Poultry with Infectious Bronchitis Virus - Variant Massachusetts infection.
Tag	hFc
Products description	Anti-Infectious Bronchitis Virus - Variant Massachusetts S1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Infectious bronchitis is an acute, highly contagious, viral disease of poultry with worldwide distribution. The most characteristic clinical signs are those derived from the respiratory disease. However, infectious bronchitis can also show renal, enteric and reproductive clinical signs. This disease causes major economic losses not only because of poor performance or decreased egg production and quality, but also because of secondary infections. Infectious bronchitis virus (IBV) is the etiological agent of infectious bronchitis, belongs to Group 3 of the genus Coronavirus. Many serotypes have been described for IBV, probably due to the frequent point mutations that occur in RNA viruses and also to recombination events demonstrated for IBV. Massachusetts type IBV variants are impacting the commercial egg production.

About GDU